We’ve reported on the RECOVERY trial several times already on the blog. It stands out as the most important trial of therapeutics in hospitalised patients with COVID19. In the last […]
REGN monoclonal antibodies work in selected hospitalised COVID-19 patients. St Emlyn’s Read More
We’ve reported on the RECOVERY trial several times already on the blog. It stands out as the most important trial of therapeutics in hospitalised patients with COVID19. This week the
JC: Aspirin is not effective for hospitalised COVID19 patients. St Emlyn’s Read More
The prevention of venous thromboembolism (VTE) has been a real concern in the management of hospitalised patients with COVID-19. We have previously discussed the role of prophylactic anticoagulation (thromboprophylaxis) for
JC: Thromboprophylaxis on the ICU for COVID-19 patients. St Emlyn’s Read More
Our regular podcast round up from February 2021. Iain and Simon highlight the key learning points from this month on the St Emlyn’s blog and podcast. Please remember to subscribe
Podcast – February 2021 Monthly Round Up Read More
The latest results on the use of convalescent plasma in Covid-19 are now out from the RECOVERY trial as a pre-print. As you know we have already covered the trial
JC: Convalescent plasma (still) does not work in COVID-19. St Emlyn’s Read More
This week the RECOVERY trial has released the first results from the Colchicine arm of the trial. We await the pre-print and the peer reviewed paper, but we are already
Colchicine does not improve mortality in COVID19. St Emlyn’s Read More
It’s very rare we produce three instalments on one particular drug for one particular condition, and certainly not within such a short time frame. However, tocilizumab has been worth it.
Tocilizumabulous? A special offer on IL-6 with Tocilizumab. Read More
In arguably the most important therapeutic news of the pandemic since Dexamethasone, the RECOVERY trial investigators have revealed the initial results on the Tocilizumab arm of the trial showing a
JC: RECOVERY trial shows Tocilizumab effective for COVID19. St Emlyn’s Read More
